APIs and intermediates should only be released for distribution to third parties after they are actually unveiled by the quality device(s).(biotech) refers to the use of cells or organisms that have been generated or modified by recombinant DNA, hybridoma, or other technological know-how to create APIs. The APIs made by biotechnological procedures